Andrew Chi, MD, PhD at NYU Langone Medical Center Explains how Gliomas in Mid-Line Locations are Distinct in Both Genetic Makeup and Behavior. Clinical Trial: ONC201 in Adults With Recurrent H3 K27M High-grade Glioma.
Gliomas in Mid-Line Locations have Distinct Make Up Defined by epigenetic and behavior
